Variable | Subgroup | Studies | n | Effect Size with 95% Confidence Interval | Heterogeneity | Test overall effects. Z(p) | Test for Subgroup Difference. Chi2 (p) | |||
---|---|---|---|---|---|---|---|---|---|---|
Tau2 | Chi2 | p | I2 | |||||||
Handgrip strength (HGS) | Â | |||||||||
 Age (years) | > 70 | 3 | 138 | 0.91 [−1.21, 3.03] | 3.36 | 52.59 | < 0.0001 | 96 | 0.84 (0.4) | 0.01 (0.94) |
≤70 | 8 | 335 | 0.84 [0.53, 1.15] | 0.08 | 11.88 | 0.1 | 41 | 5.28 (< 0.0001) | ||
 Gender | Female | 5 | 195 | 1.2 [0.88, 1.52] | 0.87 | 28.71 | < 0.0001 | 86 | 2.82 (0.005) | 0.00 (0.95) |
Male | 1 | 12 | 1.23 [−0.05, 2.51] | Not applicable | 1.88 (0.06) | |||||
 Sarcopenia diagnostics criteria | AWGS | 3 | 116 | 1.17 [0.77, 1.57] | 0.00 | 1 | 0.61 | 0 | 5.71 (< 0.0001) | 3.86 (0.14) |
EWGSOP | 4 | 198 | 0.27 [−0.02, 0.55] | 0.49 | 18.72 | 0.0003 | 84 | 0.81 (0.42) | ||
Other | 4 | 159 | 0.93[0.58, 1.29] | 1.52 | 36.12 | < 0.0001 | 92 | 1.76 (0.08) | ||
 Obesity | Yes | 4 | 177 | 1.32 [0.27, 2.38] | 1.03 | 28.56 | < 0.0001 | 89 | 2.45 (0.01) | 2.11(0.15) |
No | 7 | 296 | 0.41[0.17,0.65] | 0.43 | 29.56 | < 0.0001 | 80 | 1.52 (0.14) | ||
 Intervention duration (weeks) | > 12 | 2 | 143 | 0.88[0.03, 1.72] | 0.31 | 5.82 | < 0.0001 | 83 | 2.04(0.04) | 0.06(0.8) |
≤12 | 9 | 330 | 0.74[0.07, 1.4] | 0.86 | 60.18 | < 0.0001 | 87 | 2.18 (0.03) | ||
 Frequency (days/week) | ≥3 | 4 | 142 | 0.65[0.3, 1] | 0.13 | 5.83 | 0.12 | 49 | 2.42 (0.02) | 0.17 (0.68) |
<3 | 7 | 331 | 0.62[0.39,0.85] | 0.98 | 62.12 | < 0.0001 | 90 | 2.09 (0.04) | ||
 Mode | Progressive resistance load training | 4 | 156 | 0.04[−0.28, 0.36] | 0.29 | 10.54 | 0.01 | 72 | 0.47 (0.64) | 4.47 (0.03) |
Constant resistance load training | 7 | 317 | 0.97[0.72,0.82] | 0.59 | 37.1 | < 0.0001 | 84 | 7.8 (0.0007) | ||
 Intensity(1RM) | >60% | 3 | 75 | 4.66[2.1, 7.22] | 0.00 | 0.7 | 0.7 | 0 | 3.56 (0.0004) | 4.12 (0.04) |
≤60% | 1 | 28 | -1[−5.82, 3.82] | 3.61 | Not applicable | 0.41 (0.68) | ||||
Knee extension strength (KES) | Â | |||||||||
 Age (years) | >70 | 3 | 76 | 2.05[1.16, 2.94] | 0.34 | 4.5 | 0.11 | 56 | 3.92(< 0.0001) | 5.58(0.02) |
≤70 | 4 | 147 | 0.86[0.43, 1.28] | 0.06 | 4.38 | 0.22 | 32 | 4.51(< 0.0001) | ||
 Gender | Female | 4 | 145 | 0.96[0.49, 1.43] | 0.09 | 4.91 | 0.18 | 39 | 4.03(< 0.0001) | 5.97(0.01) |
Male | 1 | 20 | 2.64[1.38, 3.91] | Not applicable | 4.09(< 0.0001) | |||||
 Sarcopenia diagnostics criteria | AWGS | Not applicable | 1.3(0.25) | |||||||
EWGSOP | 2 | 61 | 0.7[−0.54, 1.93] | 0.61 | 4.26 | 0.04 | 77 | 1.11(0.27) | ||
Other | 5 | 162 | 1.49[0.82, 2.16] | 0.38 | 12.66 | 0.01 | 68 | 4.38(< 0.0001) | ||
 Obesity | Yes | 4 | 160 | 1.05[0.72, 1.39] | 0.00 | 1.43 | 0.7 | 0 | 6.15(< 0.0001) | 0.49(0.49) |
No | 3 | 63 | 1.56[0.94, 2.19] | 2.00 | 14.81 | 0.0006 | 86 | 1.91(0.06) | ||
 Intervention duration (weeks) | >12 | Not applicable | Not applicable | |||||||
≤12 | 7 | 223 | 1.26[0.72, 1.8] | 0.34 | 18.21 | 0.006 | 67 | 4.58(< 0.0001) | ||
 Frequency (days/week) | ≥3 | 3 | 130 | 1.44[0.70, 2.18] | 0.29 | 6.45 | 0.04 | 69 | 6.42(0.0001) | 0.3(0.58) |
<3 | 4 | 93 | 1.11[0.21, 2.01] | 0.6 | 11.03 | 0.01 | 73 | 2.43(0.02) | ||
Mode | Progressive resistance load training | 4 | 106 | 1.70[0.83, 2.57] | 0.55 | 10.33 | 0.02 | 71 | 6.47(0.0001) | 2.5(0.11) |
Constant resistance load training | 3 | 117 | 0.85[0.25,1.45] | 0.15 | 4.27 | 0.12 | 53 | 2.77(0.006) | ||
 Intensity(1RM) | >60% | 1 | 30 | 5.43[0.55, 10.31] | Not applicable | 2.18(0.03) | 0.01(0.94) | |||
≤60% | 2 | 56 | 5.75[−1.39, 9.63] | 23.09 | 6.67 | 0.010 | 85 | 1.58(0.11) | ||
Muscle Performance | Â | |||||||||
 Age (years) | >70 | 3 | 100 | −0.21[−1.00, 0.58] | 0.35 | 7.23 | 0.03 | 72 | 0.53(0.06) | 1.12(0.29) |
≤70 | 5 | 275 | 0.75[−0.84, 2.33] | 3.17 | 126.31 | < 0.0001 | 95 | 0.92(0.36) | ||
 Gender | Female | 5 | 232 | 0.18[−1.03, 1.39] | 1.80 | 71.40 | < 0.0001 | 94 | 0.3(0.77) | Not applicable |
Male | Not applicable | |||||||||
 Sarcopenia diagnostics criteria | AWGS | 1 | 71 | 2.96[2.27, 3.65] | Not applicable | 8.44 (< 0.0001) | 23.48(91.5) | |||
EWGSOP | 3 | 138 | −0.12[−1.9, 1.66] | 2.36 | 45.63 | < 0.0001 | 96 | 0.13(0.89) | ||
Other | 4 | 166 | 0.15[−0.97, 1.27] | 1.18 | 33.6 | < 0.0001 | 91 | 0.26(0.80) | ||
 Obesity | Yes | 5 | 232 | 0.18[−1.03, 1.39] | 1.80 | 71.4 | < 0.0001 | 94 | 0.3(0.53) | 0.18(0.67) |
No | 3 | 143 | 0.76[−1.63, 3.15] | 4.32 | 69.87 | < 0.0001 | 97 | 0.62(0.53) | ||
 Intervention duration (weeks) | >12 | 1 | 71 | 2.96[2.27, 3.65] | Not applicable | 8.44(< 0.0001)) | 25.31(< 0.0001) | |||
≤12 | 7 | 304 | 0.03[−0.88, 0.94] | 1.4 | 81.18 | < 0.0001 | 93 | 0.07(0.95) | ||
 Frequency (days/week) | ≥3 | 5 | 230 | 0.21[−1.02, 1.43] | 1.85 | 71.5 | < 0.0001 | 94 | 0.33(0.74) | 0.15(0.70) |
<3 | 3 | 145 | 0.72[−1.61, 1.46] | 4.12 | 70.72 | < 0.0001 | 97 | 0.61(0.54) | ||
 Mode | Progressive resistance load training | 3 | 100 | −0.2[−1.00, 0.58] | 0.35 | 7.23 | 0.03 | 72 | 0.53(0.60) | 1.12(0.29) |
Constant resistance load training | 5 | 275 | 0.75[−0.84, 2.33] | 3.17 | 126.31 | < 0.0001 | 97 | 0.92(0.36) | ||
 Intensity(1RM) | >60% | Not applicable | Not applicable | |||||||
≤60% | 2 | 72 | −0.37[−1.53, 0.79] | 0.57 | 5.22 | 0.02 | 81 | 0.63(0.53) |